Optimal Management for Primary High Grade Ta Bladder Cancer: Role of re-staging TURBT and Intravesical Adjuvant Therapy.
Tarek AjamiSunwoo HanRuben Blachman-BraunHelen Y HougenYuval AvdaMark L GonzalgoBruno NaharSanoj PunnenDipen J ParekhIsildinha M ReisChad R RitchPublished in: BJUI compass (2024)
This study highlights the significance of risk group classification, the role of re-TURBT, and the intensity of adjuvant treatment in the management of high-grade Ta tumours. A risk-adapted model is crucial to reduce the burden of unnecessary intravesical treatment and endoscopic procedures.